Key clinical point: A retrospective study suggests considerable differences in ovarian cancer survival exist between high-income countries, particularly for older patients with advanced disease.
Major finding: The 3-year all-ages net survival was highest for Norway (57%) and Australia (56%), with an overall range of 45%-57% between seven countries.
Study details: A population-based retrospective analysis of 58,161 women with ovarian cancer.
Disclosures: The study was supported by funding provided to the International Cancer Benchmarking Partnership. The authors reported having no conflicts of interest.
Cabasag CJ et al. Gynecol Oncol. 2020 Jan 28. doi: 10.1016/j.ygyno.2019.12.047.